Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G for Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") (SPRB).
- Disclosed ownership: 10%.
- Date of event: 09 Oct 2025.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 10% ownership in Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") (SPRB) on 09 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 10% | 109,649 | 0 | 109,649 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 10% | 109,649 | 0 | 109,649 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 10% | 109,649 | 0 | 109,649 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 0% | 0 | 0 | 0 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities Group LP | 0% | 0 | 0 | 0 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities GP LLC | 0% | 0 | 0 | 0 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Kenneth Griffin | 10% | 109,649 | 0 | 109,649 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |